Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.

Lemoine, M; Shimakawa, Y; Njie, R; Taal, M; Ndow, G; Chemin, I; Ghosh, S; Njai, HF; Jeng, A; Sow, A; +19 more... Toure-Kane, C; Mboup, S; Suso, P; Tamba, S; Jatta, A; Sarr, L; Kambi, A; Stanger, W; Nayagam, S; Howell, J; Mpabanzi, L; Nyan, O; Corrah, T; Whittle, H; Taylor-Robinson, SD; D'Alessandro, U; Mendy, M; Thursz, MR; PROLIFICA investigators; (2016) Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. The Lancet Global health, 4 (8). e559-67. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(16)30130-9

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2214-109X(16)30130-9

Abstract

Share

Download

Filename: Acceptability and feasibility_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar